1. Introduction
The immune system protects the body against infectious microorganisms, abnormal cells, and other potentially harmful agents. Effective immune protection requires the coordinated activity of physical barriers, innate immune cells, complement proteins, antibodies, T lymphocytes, B lymphocytes, antigen-presenting cells, and numerous cytokines and signaling molecules.
When one or more components of the immune system are absent, defective, or functionally impaired, the individual becomes susceptible to infections and, in some cases, malignancies and autoimmune or inflammatory disorders. Such conditions are collectively known as immunodeficiency disorders.
Immunodeficiencies are broadly classified into two major categories:
- Congenital or primary immunodeficiencies
- Acquired or secondary immunodeficiencies
Congenital immunodeficiencies generally result from genetic abnormalities affecting the development or function of immune cells and molecules. Acquired immunodeficiencies develop later in life as a consequence of infections, malnutrition, malignancy, medications, metabolic disorders, or other external and systemic conditions.
The clinical severity of an immunodeficiency depends on the component of immunity affected, the degree of functional impairment, and the ability of other immune pathways to compensate for the defect.
2. Definition of Immunodeficiency
Immunodeficiency is a condition in which one or more components of the immune system are absent, quantitatively reduced, or functionally defective, resulting in inadequate immune protection.
An immunodeficiency may affect:
- B lymphocytes
- T lymphocytes
- Natural killer cells
- Phagocytic cells
- Complement proteins
- Antibodies
- Cytokine signaling pathways
- Hematopoietic stem cells
- Intracellular signaling pathways required for immune-cell activation
Depending on the affected component, patients may develop recurrent bacterial, viral, fungal, or parasitic infections.
3. Classification of Immunodeficiencies
Immunodeficiencies can be classified into two major groups.
A. Congenital or Primary Immunodeficiencies
These are generally caused by inherited genetic defects.
Examples include:
- Severe combined immunodeficiency
- X-linked agammaglobulinemia
- Common variable immunodeficiency
- DiGeorge syndrome
- Chronic granulomatous disease
- Leukocyte adhesion deficiency
- Complement deficiencies
- Hyper-IgM syndromes
B. Acquired or Secondary Immunodeficiencies
These develop after birth because of another disease, infection, nutritional deficiency, treatment, or environmental factor.
Examples include:
- HIV infection
- Malnutrition
- Cancer-associated immunosuppression
- Immunosuppressive drugs
- Radiation
- Chemotherapy
- Protein-losing disorders
- Certain chronic infections
- Metabolic disorders
4. Congenital Immunodeficiencies
Congenital immunodeficiencies are also called primary immunodeficiencies or, increasingly, inborn errors of immunity.
They arise from genetic abnormalities that interfere with immune-system development, signaling, cellular function, or effector mechanisms.
The genetic defect may affect:
- Development of lymphocytes
- Antibody production
- T-cell activation
- Phagocyte function
- Complement activation
- Cytokine signaling
- Antigen processing and presentation
- Intracellular microbial killing
Some disorders become apparent during infancy, whereas others may not be recognized until adolescence or adulthood.
5. Genetic Basis of Congenital Immunodeficiency
Genetic mutations can interfere with immune function in several ways.
A mutation may:
- Prevent formation of an immune cell.
- Prevent maturation of an immune cell.
- Reduce production of an immune protein.
- Produce a structurally abnormal protein.
- Prevent signaling between immune cells.
- Interfere with intracellular killing mechanisms.
- Affect antigen receptor formation.
- Impair cytokine signaling.
- Disturb complement activity.
The inheritance pattern may be:
- X-linked
- Autosomal recessive
- Autosomal dominant
- Occasionally associated with other genomic abnormalities
The same general clinical problem, such as recurrent infection, may therefore arise from defects in completely different genes and immune pathways.
6. Major Categories of Congenital Immunodeficiency
Congenital immunodeficiencies can be broadly divided according to the immune component affected.
6.1 Predominantly Antibody Deficiencies
These mainly affect B-cell development or antibody production.
Examples:
- X-linked agammaglobulinemia
- Common variable immunodeficiency
- Selective IgA deficiency
- Hyper-IgM syndromes
Patients are particularly susceptible to recurrent infections with extracellular bacteria.
6.2 T-Cell Deficiencies
These affect cellular immunity and may also impair antibody responses because T-helper cells provide essential signals to B cells.
Examples include:
- DiGeorge syndrome
- Certain forms of severe combined immunodeficiency
These patients may develop severe viral, fungal, and opportunistic infections.
6.3 Combined Immunodeficiencies
Both cellular and humoral immunity are significantly impaired.
The most severe example is:
Severe Combined Immunodeficiency (SCID)
SCID affects the development or function of T cells and, depending on the genetic form, may also affect B cells and NK cells.
6.4 Phagocyte Deficiencies
These involve defects in neutrophil production, migration, adhesion, or microbial killing.
Examples:
- Chronic granulomatous disease
- Leukocyte adhesion deficiency
- Certain congenital neutropenias
6.5 Complement Deficiencies
Deficiency of complement components can impair:
- Opsonization
- Chemotaxis
- Inflammatory responses
- Membrane attack complex formation
Certain complement deficiencies increase susceptibility to specific bacterial infections.
7. Severe Combined Immunodeficiency
Severe Combined Immunodeficiency (SCID) represents a group of severe inherited disorders in which adaptive cellular immunity is profoundly impaired.
SCID can result from mutations affecting:
- Cytokine receptors
- Purine metabolism
- T-cell receptor signaling
- Lymphocyte development
- Antigen receptor rearrangement
The result is severe impairment of T-cell immunity, frequently accompanied by defects in B-cell and/or NK-cell function.
Clinical Features
Affected infants may develop:
- Recurrent severe infections
- Persistent viral infections
- Fungal infections
- Severe bacterial infections
- Chronic diarrhea
- Failure to thrive
- Persistent oral candidiasis
Because adaptive immunity is severely compromised, relatively harmless environmental microorganisms can cause life-threatening disease.
Importance of T Cells
T cells are central to adaptive immunity. Their absence or severe dysfunction affects:
- Direct cellular immunity
- Activation of macrophages
- B-cell help
- Antibody responses
- Immune memory
Thus, SCID demonstrates the importance of coordinated cellular and humoral immunity.
8. X-Linked Agammaglobulinemia
X-linked agammaglobulinemia is an inherited disorder affecting B-cell development.
It is associated with mutations in the BTK gene, which encodes Bruton’s tyrosine kinase.
BTK is important for signaling during B-cell maturation.
Defective BTK signaling results in:
- Failure of normal B-cell maturation
- Markedly reduced mature B cells
- Very low levels of immunoglobulins
- Impaired antibody-mediated immunity
Clinical Manifestations
Patients commonly develop recurrent bacterial infections, particularly after maternal antibodies decline during infancy.
Common infections may involve:
- Respiratory tract
- Middle ear
- Sinuses
- Skin
- Gastrointestinal tract
Because T-cell immunity remains relatively preserved, infections caused primarily by T-cell-dependent intracellular pathogens are not the defining feature.
9. Common Variable Immunodeficiency
Common Variable Immunodeficiency (CVID) is characterized mainly by impaired antibody production.
Patients typically have:
- Reduced immunoglobulin levels
- Impaired antibody responses
- Recurrent respiratory infections
Unlike some childhood immunodeficiencies, CVID may become apparent during adolescence or adulthood.
Patients may also develop:
- Chronic infections
- Autoimmune manifestations
- Gastrointestinal abnormalities
- Increased risk of certain malignancies
The exact molecular cause varies among patients.
10. Selective IgA Deficiency
Selective IgA deficiency is characterized by very low or absent serum and mucosal IgA while other major immunoglobulin classes may remain relatively preserved.
IgA is particularly important at mucosal surfaces.
It contributes to protection of:
- Respiratory tract
- Gastrointestinal tract
- Genitourinary tract
Some individuals remain asymptomatic, whereas others develop recurrent mucosal infections.
11. Hyper-IgM Syndromes
Hyper-IgM syndromes are disorders in which B cells have impaired ability to switch antibody classes.
Normally, activated B cells can undergo class-switch recombination and produce antibodies such as IgG, IgA, and IgE.
In some forms of hyper-IgM syndrome, defective interaction between T cells and B cells prevents effective class switching.
Consequently:
- IgM may be normal or elevated
- IgG is reduced
- IgA is reduced
- IgE is reduced
Patients may develop recurrent bacterial infections and, depending on the molecular defect, opportunistic infections.
12. DiGeorge Syndrome
DiGeorge syndrome is associated with abnormal development of structures derived from the embryonic pharyngeal apparatus.
A major immunological consequence is impaired development of the thymus.
The thymus is essential for:
- T-cell maturation
- T-cell selection
- Development of functional T-cell populations
Reduced thymic development therefore causes varying degrees of T-cell deficiency.
Patients may have:
- Recurrent infections
- Abnormal calcium regulation
- Congenital cardiac abnormalities
- Developmental abnormalities
The severity of immune deficiency depends on the extent of thymic abnormality.
13. Chronic Granulomatous Disease
Chronic Granulomatous Disease (CGD) is a phagocyte functional disorder caused by defects in the NADPH oxidase system.
Normally, activated phagocytes generate reactive oxygen species during the respiratory burst.
This process contributes to microbial killing.
In CGD:
Defective NADPH oxidase → impaired respiratory burst → defective intracellular killing
As a result, patients are particularly susceptible to infections with certain organisms that are relatively resistant to intracellular killing.
Granuloma Formation
Persistent microbial stimulation can cause accumulation of activated macrophages and other inflammatory cells, leading to granuloma formation.
This explains the name “granulomatous disease.”
14. Leukocyte Adhesion Deficiency
Leukocyte adhesion deficiency is caused by defects in molecules required for leukocyte adhesion and migration.
Normally:
Blood leukocyte → rolling → adhesion → transmigration → infected tissue
If adhesion is defective, leukocytes cannot efficiently leave the bloodstream and reach infected tissues.
Consequences include:
- Recurrent bacterial infections
- Poor wound healing
- Delayed separation of the umbilical cord in severe forms
- Reduced pus formation
- Persistent leukocytosis in the blood
This disorder demonstrates the importance of leukocyte trafficking in host defense.
15. Complement Deficiencies
Complement deficiencies may affect individual components of the classical, lectin, or alternative pathways, or components of the terminal pathway.
Functions affected may include:
- Opsonization
- Phagocyte recruitment
- Inflammatory activation
- Membrane attack complex formation
For example, deficiency of terminal complement components can increase susceptibility to infections caused by certain Neisseria species.
Deficiency of early classical pathway components can also be associated with increased susceptibility to immune-complex-related disease.
16. Clinical Features of Congenital Immunodeficiencies
A major clinical clue is recurrent or unusually severe infection.
Important warning signs include:
- Repeated respiratory infections
- Persistent fungal infections
- Recurrent bacterial infections
- Poor response to conventional treatment
- Infections caused by unusual organisms
- Chronic diarrhea
- Poor growth
- Persistent oral candidiasis
- Recurrent deep abscesses
- Family history of similar disease
However, not every recurrent infection indicates immunodeficiency. Frequent mild infections may occur normally, particularly in children.
17. Acquired Immunodeficiencies
Acquired immunodeficiencies are also known as secondary immunodeficiencies.
Unlike congenital disorders, they develop during an individual’s lifetime.
They can result from:
- Infectious diseases
- Malnutrition
- Cancer
- Immunosuppressive medications
- Radiation
- Chemotherapy
- Chronic systemic diseases
- Loss of immune proteins
- Bone marrow disorders
- Severe physiological stress
Secondary immunodeficiency is much more common than most severe primary immunodeficiencies.
18. Major Causes of Acquired Immunodeficiency
18.1 Infectious Diseases
Certain infections directly or indirectly suppress immune function.
The most important example is Human Immunodeficiency Virus (HIV) infection.
HIV primarily targets cells expressing CD4, especially:
- CD4+ T lymphocytes
- Macrophages
- Certain dendritic-cell populations
Progressive loss of functional CD4+ T cells produces severe immune dysfunction.
18.2 Malnutrition
Adequate nutrition is essential for immune-cell production and function.
Deficiencies of:
- Protein
- Zinc
- Iron
- Vitamins
- Other essential nutrients
can impair immune responses.
Protein-energy malnutrition can affect both innate and adaptive immunity.
Possible consequences include:
- Reduced lymphocyte function
- Impaired antibody responses
- Reduced complement production
- Impaired barrier integrity
- Poor wound healing
18.3 Immunosuppressive Drugs
Many medications intentionally suppress immune activity.
Examples include:
- Glucocorticoids
- Cytotoxic chemotherapy
- Certain biologic agents
- Drugs used after organ transplantation
These treatments may suppress:
- T-cell activation
- B-cell function
- Cytokine production
- Leukocyte proliferation
The degree of immune suppression depends on the drug, dose, duration, and combination of therapies.
18.4 Malignancy
Cancers of the blood and immune system can interfere with normal immune function.
Examples include:
- Leukemia
- Lymphoma
- Plasma-cell disorders
Malignancy may cause immunodeficiency through:
- Abnormal immune-cell production
- Bone marrow replacement
- Reduced normal leukocyte formation
- Abnormal antibody production
- Treatment-related immunosuppression
18.5 Radiation and Chemotherapy
Radiation and cytotoxic chemotherapy can damage rapidly dividing cells.
Because hematopoietic cells divide actively, these treatments may reduce:
- Neutrophils
- Lymphocytes
- Platelets
- Other blood-cell populations
Severe neutropenia can greatly increase the risk of bacterial and fungal infections.
19. HIV Infection and Immunodeficiency
HIV is a major cause of acquired immunodeficiency.
The virus enters susceptible cells through interactions involving:
- CD4
- Chemokine co-receptors such as CCR5 or CXCR4
After entry, viral replication can progressively reduce functional CD4+ T-cell populations.
Consequences of CD4+ T-Cell Loss
CD4+ T cells coordinate many immune responses.
Their loss affects:
- Macrophage activation
- B-cell antibody responses
- T-cell coordination
- Immune memory
- Defense against opportunistic microorganisms
Advanced HIV infection can therefore lead to severe susceptibility to opportunistic infections and certain malignancies.
20. Opportunistic Infections
An opportunistic infection is an infection caused by an organism that normally causes little or no disease in individuals with intact immunity but can cause significant disease when immune defenses are weakened.
Examples include infections caused by:
- Certain fungi
- Intracellular bacteria
- Viruses
- Protozoa
The type of opportunistic infection often provides information about which component of immunity is impaired.
21. Mechanisms of Acquired Immunodeficiency
Acquired immunodeficiency can occur through several mechanisms.
Mechanism 1: Destruction of Immune Cells
Example:
HIV infection → CD4+ T-cell loss → impaired immune coordination
Mechanism 2: Reduced Immune-Cell Production
Example:
Chemotherapy → bone marrow suppression → reduced leukocytes
Mechanism 3: Functional Suppression
Example:
Immunosuppressive drug → reduced lymphocyte activation
Mechanism 4: Nutritional Deficiency
Malnutrition → impaired immune-cell metabolism and production
Mechanism 5: Loss of Immune Proteins
Protein-losing conditions may cause loss of immunoglobulins and other important plasma proteins.
22. Difference Between Congenital and Acquired Immunodeficiencies
| Feature | Congenital Immunodeficiency | Acquired Immunodeficiency |
|---|---|---|
| Origin | Genetic | Develops during life |
| Alternative name | Primary immunodeficiency | Secondary immunodeficiency |
| Onset | Often early, but may occur later | Usually after birth |
| Cause | Gene mutation or inherited defect | Infection, disease, drugs, malnutrition, etc. |
| Examples | SCID, X-linked agammaglobulinemia, CGD | HIV, chemotherapy-associated immunosuppression |
| Family history | May be present | Usually absent |
| Prevention | Genetic counseling and appropriate medical care | Management of underlying cause where possible |
| Treatment | Depends on genetic and immune defect | Treat underlying cause and restore immune function when possible |
23. Diagnosis of Immunodeficiency
Diagnosis begins with detailed clinical history and physical examination.
Important aspects include:
- Frequency of infections
- Severity of infections
- Type of microorganism
- Age at onset
- Response to treatment
- Family history
- Vaccination history
- Nutritional status
- Medication history
Laboratory investigations may include:
Complete Blood Count
Provides information about:
- Neutrophils
- Lymphocytes
- Other blood-cell populations
Immunoglobulin Measurement
Serum levels of:
- IgG
- IgA
- IgM
- Sometimes IgE
may be measured.
Lymphocyte Subset Analysis
Flow cytometry can identify:
- T cells
- B cells
- NK cells
Complement Testing
Tests such as CH50 and AH50 can help evaluate complement pathways.
Functional Tests
Depending on the suspected disorder, tests may evaluate:
- Neutrophil oxidative burst
- Antibody responses
- Lymphocyte proliferation
- Cytokine signaling
- Specific immune-cell functions
Genetic Testing
Genetic analysis can identify mutations responsible for many congenital immunodeficiencies.
24. Treatment of Congenital Immunodeficiencies
Treatment depends on the defective immune component.
Immunoglobulin Replacement
Patients with significant antibody-production defects may receive immunoglobulin replacement.
It provides passive antibodies that help protect against infections.
Hematopoietic Stem Cell Transplantation
Hematopoietic stem-cell transplantation can provide functional immune-cell precursors.
It is particularly important for selected severe immunodeficiencies such as severe forms of SCID.
Gene Therapy
For certain genetic immunodeficiencies, gene therapy can introduce a functional copy of the defective gene into appropriate hematopoietic cells.
Antimicrobial Therapy
Patients may require:
- Prompt treatment of infections
- Preventive antimicrobial therapy
- Antifungal treatment
- Antiviral treatment when indicated
Supportive Treatment
Supportive measures may include:
- Nutritional support
- Vaccination strategies appropriate to the immune defect
- Management of complications
- Infection prevention
25. Treatment of Acquired Immunodeficiencies
Treatment primarily focuses on identifying and correcting the underlying cause.
Examples include:
HIV infection → antiretroviral therapy
Drug-induced immunosuppression → adjustment when medically appropriate
Malnutrition → nutritional rehabilitation
Chemotherapy-associated neutropenia → appropriate infection management and supportive therapy
Malignancy → treatment of underlying cancer
The goal is not simply to treat infections but also to restore or preserve immune function whenever possible.
26. Immunodeficiency and Vaccination
Vaccination is an important component of infection prevention, but vaccine selection must be individualized in patients with significant immunodeficiency.
Some live vaccines may pose risks in individuals with severe defects in cellular immunity.
Therefore, the type and severity of immunodeficiency must be considered before administration of certain vaccines.
Inactivated or non-live vaccines may be safer in many immunocompromised individuals, although their effectiveness can be reduced when immune responses are severely impaired.
27. Immunodeficiency and Autoimmunity
Immunodeficiency does not always result only in infections.
Some immunodeficiency disorders are associated with increased risk of:
- Autoimmune disease
- Chronic inflammation
- Abnormal lymphocyte activation
This may occur because the genetic defect affects immune tolerance as well as host defense.
Therefore, the immune system can simultaneously show inadequate defense against microorganisms and inappropriate reactivity against self-antigens.
28. Immunodeficiency and Malignancy
The immune system contributes to surveillance against abnormal cells.
Severe or prolonged immunodeficiency can increase the risk of certain malignancies.
This may occur because:
- Immune surveillance is reduced.
- Certain oncogenic viruses are less effectively controlled.
- Abnormal lymphocyte populations may expand.
- Chronic immune dysregulation may occur.
Thus, immunodeficiency can influence both infection susceptibility and cancer risk.
29. Relationship Between Immune Component and Infection
| Defective Component | Major Consequence |
|---|---|
| B cells/antibodies | Recurrent extracellular bacterial infections |
| T cells | Viral, fungal and opportunistic infections |
| Combined T and B defects | Severe broad-spectrum infections |
| Neutrophils | Recurrent bacterial and fungal infections |
| Phagocyte killing mechanisms | Deep and recurrent infections |
| Complement | Susceptibility to selected bacterial infections |
| NK-cell function | Impaired defense against some viral infections |
30. General Mechanism of Immunodeficiency
Genetic defect or acquired cause
↓
Defect in immune-cell development/function
↓
Reduced immune response
↓
Failure of pathogen recognition, killing, or elimination
↓
Persistent or recurrent infection
↓
Tissue damage and complications
↓
Possible chronic inflammation, malignancy, or organ dysfunction
31. Comparison of Major Primary Immunodeficiencies
| Disorder | Major Defect | Important Consequence |
|---|---|---|
| SCID | Severe lymphocyte dysfunction | Severe recurrent infections |
| X-linked agammaglobulinemia | BTK defect and impaired B-cell maturation | Severe antibody deficiency |
| CVID | Impaired antibody production | Recurrent respiratory infections |
| DiGeorge syndrome | Thymic developmental defect | T-cell deficiency |
| CGD | NADPH oxidase defect | Impaired phagocyte killing |
| Leukocyte adhesion deficiency | Defective leukocyte adhesion | Impaired migration to tissues |
| Complement deficiency | Defective complement pathway | Recurrent susceptibility to selected infections |
.
